Filing Details
- Accession Number:
- 0001144204-18-014486
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-13 22:00:09
- Reporting Period:
- 2016-07-13
- Accepted Time:
- 2018-03-13 22:00:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551986 | Innovate Biopharmaceuticals Inc. | INNT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251818 | H David Clarke | 2655 First Street, Suite 250 Simi Valley CA 93065 | Former Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-13 | 15,000 | $4.50 | 445,043 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-01-24 | 175,000 | $0.00 | 620,043 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-03-16 | 70,000 | $1.50 | 690,043 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-06-23 | 172,414 | $0.58 | 862,457 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-06-30 | 33,621 | $0.00 | 896,078 | No | 4 | A | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-06-30 | 13,467 | $0.00 | 909,545 | No | 4 | A | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-11-09 | 100,000 | $0.00 | 1,009,545 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-11-29 | 366,159 | $0.45 | 1,375,704 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2018-01-24 | 17,746 | $0.00 | 1,393,450 | No | 4 | A | Indirect | See footnote |
| Common Stock | Acquisiton | 2018-01-25 | 25,000 | $0.00 | 1,418,450 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2018-01-26 | 300,000 | $0.35 | 1,718,450 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct | |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | A | Indirect | See footnote |
| No | 4 | A | Indirect | See footnote |
| No | 4 | A | Direct | |
| No | 4 | P | Indirect | See footnote |
| No | 4 | A | Indirect | See footnote |
| No | 4 | A | Direct | |
| No | 4 | P | Indirect | See footnote |
Footnotes
- Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.
- Reporting Person's beneficial ownership includes: 71,402 shares of common stock held by his spouse and 1,063,350 shares of common stock held by GSB Holdings, Inc., a corporation owned by his spouse and children.
Billionaire Hedge Funds
